Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-07-22

AUTHORS

Heng-Chen Yao, Shu-Qin Liu, Ke Yu, Min Zhou, Le-Xin Wang

ABSTRACT

Our objective was to investigate the effect of interleukin-2 (IL-2) on the cytotoxic activity of natural killer (NK) cells in patients with chronic heart failure (CHF). Natural killer cells were isolated from 48 patients with CHF and 30 healthy subjects. The cytotoxic activities of the NK cells were assessed with the thiazolyl blue tetrazolium bromide (MTT) approach. Interleukin-2 (20 ng/ml) was added to the cell culture to stimulate the cytotoxicity of the NK cells. The cell number in the New York Heart Association (NYHA) class II, III, and IV was 27.9 ± 2.5, 21.2 ± 2.7, and 16.8 ± 2.6 cells/μl, respectively, which was significantly lower than in the control group (31.2 ± 3.6 cells/μl, all P < 0.01). The cytotoxic activities in NYHA II, III, and IV groups were 28.6% ± 3.2%, 16.0% ± 2.2%, and 12.1% ± 2.9%, respectively, which was lower than in the control group (41.0% ± 4.0%, all P < 0.01). Univariate analysis showed a close correlation between the NK cell cytotoxicity and the left ventricular ejection fraction (r = 0.949, P < 0.001). After in vitro treatment with IL-2, there was a significant increase in the cytotoxic activity of the NK cells in the control and the three heart failure groups (all P < 0.01). There is a significant reduction in the number and the cytotoxic activity of circulating NK cells in patients with CHF. The degree of NK cell deficiency is closely related to the severity of left ventricular dysfunction. In vitro treatment with IL-2 improves the cytotoxic activity of NK cell from the CHF patients. More... »

PAGES

283-286

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00380-008-1123-0

DOI

http://dx.doi.org/10.1007/s00380-008-1123-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047142153

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19626401


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chronic Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coculture Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytotoxicity, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukin-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "K562 Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Killer Cells, Natural", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke Volume", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Dysfunction, Left", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Liaocheng People\u2019s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Cardiology, Liaocheng People\u2019s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yao", 
        "givenName": "Heng-Chen", 
        "id": "sg:person.01003551076.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003551076.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Liaocheng People\u2019s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Cardiology, Liaocheng People\u2019s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Shu-Qin", 
        "id": "sg:person.0726267305.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726267305.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Liaocheng People\u2019s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Cardiology, Liaocheng People\u2019s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yu", 
        "givenName": "Ke", 
        "id": "sg:person.01117777476.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117777476.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Liaocheng People\u2019s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Cardiology, Liaocheng People\u2019s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Min", 
        "id": "sg:person.01166112676.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166112676.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Biomedical Sciences, Charles Sturt University, 2678, Wagga Wagga, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1037.5", 
          "name": [
            "School of Biomedical Sciences, Charles Sturt University, 2678, Wagga Wagga, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Le-Xin", 
        "id": "sg:person.01304365176.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304365176.60"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00380-006-0955-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025134138", 
          "https://doi.org/10.1007/s00380-006-0955-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-007-0977-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040450245", 
          "https://doi.org/10.1007/s00380-007-0977-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-07-22", 
    "datePublishedReg": "2009-07-22", 
    "description": "Our objective was to investigate the effect of interleukin-2 (IL-2) on the cytotoxic activity of natural killer (NK) cells in patients with chronic heart failure (CHF). Natural killer cells were isolated from 48 patients with CHF and 30 healthy subjects. The cytotoxic activities of the NK cells were assessed with the thiazolyl blue tetrazolium bromide (MTT) approach. Interleukin-2 (20 ng/ml) was added to the cell culture to stimulate the cytotoxicity of the NK cells. The cell number in the New York Heart Association (NYHA) class II, III, and IV was 27.9 \u00b1 2.5, 21.2 \u00b1 2.7, and 16.8 \u00b1 2.6 cells/\u03bcl, respectively, which was significantly lower than in the control group (31.2 \u00b1 3.6 cells/\u03bcl, all P < 0.01). The cytotoxic activities in NYHA II, III, and IV groups were 28.6% \u00b1 3.2%, 16.0% \u00b1 2.2%, and 12.1% \u00b1 2.9%, respectively, which was lower than in the control group (41.0% \u00b1 4.0%, all P < 0.01). Univariate analysis showed a close correlation between the NK cell cytotoxicity and the left ventricular ejection fraction (r = 0.949, P < 0.001). After in vitro treatment with IL-2, there was a significant increase in the cytotoxic activity of the NK cells in the control and the three heart failure groups (all P < 0.01). There is a significant reduction in the number and the cytotoxic activity of circulating NK cells in patients with CHF. The degree of NK cell deficiency is closely related to the severity of left ventricular dysfunction. In vitro treatment with IL-2 improves the cytotoxic activity of NK cell from the CHF patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00380-008-1123-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1095887", 
        "issn": [
          "0910-8327", 
          "1615-2573"
        ], 
        "name": "Heart and Vessels", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "keywords": [
      "chronic heart failure", 
      "natural killer cells", 
      "NK cells", 
      "interleukin-2", 
      "killer cells", 
      "heart failure", 
      "New York Heart Association class II", 
      "control group", 
      "left ventricular ejection fraction", 
      "cytotoxic activity", 
      "NK cell deficiency", 
      "left ventricular dysfunction", 
      "NK cell cytotoxicity", 
      "ventricular ejection fraction", 
      "heart failure group", 
      "NYHA II", 
      "ventricular dysfunction", 
      "CHF patients", 
      "ejection fraction", 
      "failure group", 
      "univariate analysis", 
      "cell deficiency", 
      "healthy subjects", 
      "vitro treatment", 
      "patients", 
      "cell cytotoxicity", 
      "class II", 
      "cells/", 
      "cell number", 
      "significant increase", 
      "significant reduction", 
      "cells", 
      "treatment", 
      "cell cultures", 
      "group", 
      "cytotoxicity", 
      "close correlation", 
      "failure", 
      "activity", 
      "dysfunction", 
      "severity", 
      "subjects", 
      "deficiency", 
      "control", 
      "number", 
      "increase", 
      "correlation", 
      "reduction", 
      "effect", 
      "objective", 
      "culture", 
      "fraction", 
      "degree", 
      "analysis", 
      "approach", 
      "thiazolyl blue tetrazolium bromide (MTT) approach", 
      "blue tetrazolium bromide (MTT) approach", 
      "tetrazolium bromide (MTT) approach", 
      "bromide (MTT) approach", 
      "York Heart Association (NYHA) class II", 
      "Heart Association (NYHA) class II", 
      "Association (NYHA) class II"
    ], 
    "name": "Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure", 
    "pagination": "283-286", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047142153"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00380-008-1123-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19626401"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00380-008-1123-0", 
      "https://app.dimensions.ai/details/publication/pub.1047142153"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_490.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00380-008-1123-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-008-1123-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-008-1123-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-008-1123-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-008-1123-0'


 

This table displays all metadata directly associated to this object as RDF triples.

239 TRIPLES      22 PREDICATES      109 URIs      98 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00380-008-1123-0 schema:about N0511b659eef64ce5af6ad1f065f5e776
2 N16e0c162388947879f0586e35612efec
3 N2cbfcd9a47b94921b03a2997a233491e
4 N32f40bbf9ed4461b9578d3f82c46ef08
5 N3340790f4e8645bdab39431b1f9d2ca7
6 N3739b83f143f47629fb6104a940832b7
7 N412ffe288dd743f289bfae8c7ce77750
8 N4559f5f9c39e4f7888e06f9a9c69bcc3
9 N590c4cd2437b460497b330506b8fe9d1
10 N6cad5c3616174f018f2565fe8bddec15
11 N7c27b59277524f9e8e565e35d2f26939
12 N86a6536edf604501b598d0731e06575a
13 N8864ca0cd8bb433e9c658bcbeddf1e03
14 N9029d82fa4594457bd01a9e721e5de4c
15 Nbf725940c48747c997f9deb54a77e361
16 Nbf7f0755f33e4abe9ed142164a4a5bce
17 Nc079758906ae48a8b27e0987c9e7c28c
18 Ndf052aa01bba48e586eef55b99fc5503
19 anzsrc-for:11
20 anzsrc-for:1102
21 anzsrc-for:1107
22 schema:author N9f516433ebb542ccb905149e8f0efd4e
23 schema:citation sg:pub.10.1007/s00380-006-0955-8
24 sg:pub.10.1007/s00380-007-0977-x
25 schema:datePublished 2009-07-22
26 schema:datePublishedReg 2009-07-22
27 schema:description Our objective was to investigate the effect of interleukin-2 (IL-2) on the cytotoxic activity of natural killer (NK) cells in patients with chronic heart failure (CHF). Natural killer cells were isolated from 48 patients with CHF and 30 healthy subjects. The cytotoxic activities of the NK cells were assessed with the thiazolyl blue tetrazolium bromide (MTT) approach. Interleukin-2 (20 ng/ml) was added to the cell culture to stimulate the cytotoxicity of the NK cells. The cell number in the New York Heart Association (NYHA) class II, III, and IV was 27.9 ± 2.5, 21.2 ± 2.7, and 16.8 ± 2.6 cells/μl, respectively, which was significantly lower than in the control group (31.2 ± 3.6 cells/μl, all P < 0.01). The cytotoxic activities in NYHA II, III, and IV groups were 28.6% ± 3.2%, 16.0% ± 2.2%, and 12.1% ± 2.9%, respectively, which was lower than in the control group (41.0% ± 4.0%, all P < 0.01). Univariate analysis showed a close correlation between the NK cell cytotoxicity and the left ventricular ejection fraction (r = 0.949, P < 0.001). After in vitro treatment with IL-2, there was a significant increase in the cytotoxic activity of the NK cells in the control and the three heart failure groups (all P < 0.01). There is a significant reduction in the number and the cytotoxic activity of circulating NK cells in patients with CHF. The degree of NK cell deficiency is closely related to the severity of left ventricular dysfunction. In vitro treatment with IL-2 improves the cytotoxic activity of NK cell from the CHF patients.
28 schema:genre article
29 schema:inLanguage en
30 schema:isAccessibleForFree false
31 schema:isPartOf N7426dcd02ee144efbf37715a9a077252
32 Ne3f11e654b414dd38273c937f039e32b
33 sg:journal.1095887
34 schema:keywords Association (NYHA) class II
35 CHF patients
36 Heart Association (NYHA) class II
37 NK cell cytotoxicity
38 NK cell deficiency
39 NK cells
40 NYHA II
41 New York Heart Association class II
42 York Heart Association (NYHA) class II
43 activity
44 analysis
45 approach
46 blue tetrazolium bromide (MTT) approach
47 bromide (MTT) approach
48 cell cultures
49 cell cytotoxicity
50 cell deficiency
51 cell number
52 cells
53 cells/
54 chronic heart failure
55 class II
56 close correlation
57 control
58 control group
59 correlation
60 culture
61 cytotoxic activity
62 cytotoxicity
63 deficiency
64 degree
65 dysfunction
66 effect
67 ejection fraction
68 failure
69 failure group
70 fraction
71 group
72 healthy subjects
73 heart failure
74 heart failure group
75 increase
76 interleukin-2
77 killer cells
78 left ventricular dysfunction
79 left ventricular ejection fraction
80 natural killer cells
81 number
82 objective
83 patients
84 reduction
85 severity
86 significant increase
87 significant reduction
88 subjects
89 tetrazolium bromide (MTT) approach
90 thiazolyl blue tetrazolium bromide (MTT) approach
91 treatment
92 univariate analysis
93 ventricular dysfunction
94 ventricular ejection fraction
95 vitro treatment
96 schema:name Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure
97 schema:pagination 283-286
98 schema:productId Nd43139e089a241a9a5e1e5cbd4f526cd
99 Ne0cd2e5d63d141a9a83a95a6dcf72fa7
100 Ne61055bf8e144d29a2b98416b3876e90
101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047142153
102 https://doi.org/10.1007/s00380-008-1123-0
103 schema:sdDatePublished 2022-01-01T18:20
104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
105 schema:sdPublisher N60df218872d04a738a84b99f7e32cd09
106 schema:url https://doi.org/10.1007/s00380-008-1123-0
107 sgo:license sg:explorer/license/
108 sgo:sdDataset articles
109 rdf:type schema:ScholarlyArticle
110 N0511b659eef64ce5af6ad1f065f5e776 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Chronic Disease
112 rdf:type schema:DefinedTerm
113 N16e0c162388947879f0586e35612efec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Heart Failure
115 rdf:type schema:DefinedTerm
116 N2cbfcd9a47b94921b03a2997a233491e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Humans
118 rdf:type schema:DefinedTerm
119 N32f40bbf9ed4461b9578d3f82c46ef08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Lymphocyte Count
121 rdf:type schema:DefinedTerm
122 N3340790f4e8645bdab39431b1f9d2ca7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Aged
124 rdf:type schema:DefinedTerm
125 N3739b83f143f47629fb6104a940832b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Coculture Techniques
127 rdf:type schema:DefinedTerm
128 N412ffe288dd743f289bfae8c7ce77750 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Adult
130 rdf:type schema:DefinedTerm
131 N42abef542cec4d2683e8ed4744e68ea0 rdf:first sg:person.01117777476.42
132 rdf:rest Nd5e78a3ea1e24f9ab252ddeb635814a7
133 N4559f5f9c39e4f7888e06f9a9c69bcc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Male
135 rdf:type schema:DefinedTerm
136 N590c4cd2437b460497b330506b8fe9d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Middle Aged
138 rdf:type schema:DefinedTerm
139 N60df218872d04a738a84b99f7e32cd09 schema:name Springer Nature - SN SciGraph project
140 rdf:type schema:Organization
141 N6cad5c3616174f018f2565fe8bddec15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name K562 Cells
143 rdf:type schema:DefinedTerm
144 N7426dcd02ee144efbf37715a9a077252 schema:issueNumber 4
145 rdf:type schema:PublicationIssue
146 N7c27b59277524f9e8e565e35d2f26939 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Ventricular Dysfunction, Left
148 rdf:type schema:DefinedTerm
149 N86a6536edf604501b598d0731e06575a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Female
151 rdf:type schema:DefinedTerm
152 N8864ca0cd8bb433e9c658bcbeddf1e03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Cytotoxicity, Immunologic
154 rdf:type schema:DefinedTerm
155 N9029d82fa4594457bd01a9e721e5de4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Severity of Illness Index
157 rdf:type schema:DefinedTerm
158 N9f516433ebb542ccb905149e8f0efd4e rdf:first sg:person.01003551076.87
159 rdf:rest Nefd2bf3a98144a7b94581c2e628985aa
160 Nbf725940c48747c997f9deb54a77e361 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Interleukin-2
162 rdf:type schema:DefinedTerm
163 Nbf7f0755f33e4abe9ed142164a4a5bce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Stroke Volume
165 rdf:type schema:DefinedTerm
166 Nc079758906ae48a8b27e0987c9e7c28c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Case-Control Studies
168 rdf:type schema:DefinedTerm
169 Nd22f68f78284423bac8f2d541a8c0023 rdf:first sg:person.01304365176.60
170 rdf:rest rdf:nil
171 Nd43139e089a241a9a5e1e5cbd4f526cd schema:name doi
172 schema:value 10.1007/s00380-008-1123-0
173 rdf:type schema:PropertyValue
174 Nd5e78a3ea1e24f9ab252ddeb635814a7 rdf:first sg:person.01166112676.75
175 rdf:rest Nd22f68f78284423bac8f2d541a8c0023
176 Ndf052aa01bba48e586eef55b99fc5503 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Killer Cells, Natural
178 rdf:type schema:DefinedTerm
179 Ne0cd2e5d63d141a9a83a95a6dcf72fa7 schema:name dimensions_id
180 schema:value pub.1047142153
181 rdf:type schema:PropertyValue
182 Ne3f11e654b414dd38273c937f039e32b schema:volumeNumber 24
183 rdf:type schema:PublicationVolume
184 Ne61055bf8e144d29a2b98416b3876e90 schema:name pubmed_id
185 schema:value 19626401
186 rdf:type schema:PropertyValue
187 Nefd2bf3a98144a7b94581c2e628985aa rdf:first sg:person.0726267305.47
188 rdf:rest N42abef542cec4d2683e8ed4744e68ea0
189 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
190 schema:name Medical and Health Sciences
191 rdf:type schema:DefinedTerm
192 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
193 schema:name Cardiorespiratory Medicine and Haematology
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
196 schema:name Immunology
197 rdf:type schema:DefinedTerm
198 sg:journal.1095887 schema:issn 0910-8327
199 1615-2573
200 schema:name Heart and Vessels
201 schema:publisher Springer Nature
202 rdf:type schema:Periodical
203 sg:person.01003551076.87 schema:affiliation grid-institutes:None
204 schema:familyName Yao
205 schema:givenName Heng-Chen
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003551076.87
207 rdf:type schema:Person
208 sg:person.01117777476.42 schema:affiliation grid-institutes:None
209 schema:familyName Yu
210 schema:givenName Ke
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117777476.42
212 rdf:type schema:Person
213 sg:person.01166112676.75 schema:affiliation grid-institutes:None
214 schema:familyName Zhou
215 schema:givenName Min
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166112676.75
217 rdf:type schema:Person
218 sg:person.01304365176.60 schema:affiliation grid-institutes:grid.1037.5
219 schema:familyName Wang
220 schema:givenName Le-Xin
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304365176.60
222 rdf:type schema:Person
223 sg:person.0726267305.47 schema:affiliation grid-institutes:None
224 schema:familyName Liu
225 schema:givenName Shu-Qin
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726267305.47
227 rdf:type schema:Person
228 sg:pub.10.1007/s00380-006-0955-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025134138
229 https://doi.org/10.1007/s00380-006-0955-8
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/s00380-007-0977-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1040450245
232 https://doi.org/10.1007/s00380-007-0977-x
233 rdf:type schema:CreativeWork
234 grid-institutes:None schema:alternateName Department of Cardiology, Liaocheng People’s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China
235 schema:name Department of Cardiology, Liaocheng People’s Hospital and Liaocheng Clinical School of Taishan Medical College, Liaocheng City, Shandong Province, PR China
236 rdf:type schema:Organization
237 grid-institutes:grid.1037.5 schema:alternateName School of Biomedical Sciences, Charles Sturt University, 2678, Wagga Wagga, NSW, Australia
238 schema:name School of Biomedical Sciences, Charles Sturt University, 2678, Wagga Wagga, NSW, Australia
239 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...